tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Abbott announces global partnership with Medtronic

Abbott announced a unique global partnership with Medtronic to collaborate on an integrated continuous glucose monitoring, or CGM, system based on Abbott’s most advanced, world-leading1 FreeStyle Libre technology that will connect with Medtronic’s automated insulin delivery, or AID, and smart insulin pen systems. The integration of Abbott’s CGM sensor with Medtronic’s AID algorithms will enable automatic adjustments of insulin to keep glucose in range. The CGM sensor, designed to work exclusively with Medtronic devices, will be developed by Abbott and sold by Medtronic. AID systems improve health outcomes while reducing the burden of constant decision-making for people with diabetes who use intensive insulin as part of their overall therapy. AID systems can benefit people with both Type 1 and Type 2 diabetes who require multiple daily injections of rapid-acting insulin, currently estimated at more than 11 million people globally. Financial terms of the partnership and timing for commercial availability were not disclosed.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1